Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -14,562 | -18,633 | N/A |
| Depreciation Amortization | 78 | 32 | N/A |
| Accounts receivable | N/A | -738 | N/A |
| Accounts payable and accrued liabilities | -257 | 172 | N/A |
| Other Working Capital | 315 | -1,253 | N/A |
| Other Operating Activity | 1,322 | 1,297 | 0 |
| Operating Cash Flow | $-13,104 | $-19,123 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -4 | N/A |
| Sale Of Investment | N/A | 3,400 | N/A |
| Investing Cash Flow | $N/A | $3,396 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Repayment | 11,387 | N/A | N/A |
| Common Stock Issued | 2 | 4 | N/A |
| Other Financing Activity | -377 | 14,990 | 0 |
| Financing Cash Flow | $11,012 | $14,994 | $N/A |
| Beginning Cash Position | 6,396 | 7,129 | N/A |
| End Cash Position | 4,304 | 6,396 | N/A |
| Net Cash Flow | $-2,092 | $-733 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -13,104 | -19,123 | N/A |
| Capital Expenditure | N/A | -4 | N/A |
| Free Cash Flow | -13,104 | -19,127 | 0 |